Biotechnology News Magazine keeps you up to date on what is happening in the biotech field.
It is the essential industry source for biotech, pharma and life science news. The weekly publication covers developments in the industry and its impact on regulation, funding and company strategy.
If you’re interested in biotech, then you will love this free online magazine. Make sure you never miss any biotech news by adding Biotechnology News Magazine to your news reader of choice.
Variantyx Enters Women’s Health Market with WGS-Based Prenatal Test for High-Risk Pregnancies
Genomic Unity® tests have been instrumental in resolving many complex patient cases. Variantyx pairs the patient’s complete DNA sequence with proprietary data analysis algorithms and phenotype-driven filters to uniquely identify and definitively report on all major types of genetic variation within a single assay.
PromoCell Announces Successful Completion of a Comprehensive EXCiPACT™ Audit
"To achieve EXCiPACT GMP certification, PromoCell was required to demonstrate that its pharmaceutical excipients are manufactured according to the GMP guidelines, etc.
GeneDx Launches Several New Genetic Tests
GeneDx new genetic tests include repeat expansion analysis for spinocerebellar ataxia (SCA), Friedreich ataxia, and other common forms of hereditary ataxias.
Nanoscope Therapeutics Receives Orphan Drug Designation for Gene Therapy of Blindness
"Currently, there are no approved therapies for Stargardt Disease" said Sulagna Bhattacharya, Chief Executive Officer of Nanoscope. "We are excited by the potential of ambient light activatable Multi-Characteristic Opsin (MCO) based photosensitization of retinal neurons for treating Stargardt disease in a gene agnostic manner."
Babson Diagnostics First to Conduct Full Blood Panel Testing from a Finger Sample in a Retail Setting
The startup recently completed a pivotal clinical study called “Dandelion Alpha,” which demonstrated the effectiveness of their proprietary sample collection, sample handling, and analysis technology.
European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
“Avelumab is the only immunotherapy to demonstrate a significant improvement in overall survival in the first-line setting in a Phase III study in advanced or metastatic bladder cancer.